Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 101.885 million compared to CNY 126.174 million a year ago. Operating loss was CNY 44.780 million compared to CNY 7.290 million a year ago. Net loss was CNY 62.820 million compared to CNY 12.926 million a year ago. Basic loss per share from continuing operations was CNY 0.0952 compared to CNY 0.0196 a year ago.